A detailed history of Armistice Capital, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 1,896,575 shares of CYTK stock, worth $92.7 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares
1,896,575
Previous 2,065,991 8.2%
Holding current value
$92.7 Million
Previous $112 Million 10.54%
% of portfolio
1.66%
Previous 1.46%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$51.22 - $60.16 $8.68 Million - $10.2 Million
-169,416 Reduced 8.2%
1,896,575 $100 Million
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $25.9 Million - $40.5 Million
540,303 Added 35.41%
2,065,991 $112 Million
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $97.3 Million - $165 Million
1,525,688 New
1,525,688 $107 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.6B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.